Delivery Order SPE2DR25D3103-SPE2DR26F9J94
- Not listed
- The Defense Logistics Agency awarded a $87,253.24 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price, non-set-aside contract is set to be completed by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $126,044.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order issued without a set-aside designation, reflecting competitive procurement practices. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $89,703.00 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military and federal healthcare systems. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is listed...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,960.42 firm fixed price delivery order for DARZALEX FASPRO 1,800MG-30,000 15ML, with an ultimate completion date of July 8, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $31,511.05 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military and federal healthcare systems. Issued on November 25, 2025, with an ultimate completion date of December 17, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $89,703.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is unclassified as a set-aside and has an ultimate completion date of September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J94Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $75,626.52 to AmerisourceBergen Drug Corp for supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The firm's track record of successfully fulfilling federal medical supply requirements through open competition demonstrates its capability to meet the specialized pharmaceutical needs of DoD and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.6k | 11/25/25 |